Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis

Reproducibility of Histologic Classification in Nonfibrotic Myeloproliferative Neoplasia

(2011) Suzanne M. Koopmans et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

The JAK2V617F allele burden and STAT3- and STAT5 phosphorylation in myeloproliferative neoplasms: early prefibrotic myelofibrosis compared with essential thrombocythemia, polycythemia vera and myelofibrosis

(2011) MALENE RISUM et al.   APMIS

EZH2 mutational status predicts poor survival in myelofibrosis

(2011) P. Guglielmelli et al.   BLOOD

Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification

(2011) J. Thiele et al.   BLOOD

Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

(2011) Tiziano Barbui et al.   JOURNAL OF CLINICAL ONCOLOGY

Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients

(2011) A Pardanani et al.   LEUKEMIA

In Vitro Megakaryocyte Differentiation and Proplatelet Formation in Ph-Negative Classical Myeloproliferative Neoplasms: Distinct Patterns in the Different Clinical Phenotypes

(2011) Alessandra Balduini et al.   PLoS One

The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis

(2010) D. W. ORR et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Sex differences in the JAK2V617F allele burden in chronic myeloproliferative disorders

(2010) B. L. Stein et al.   HAEMATOLOGICA

Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis

(2010) Maud Brousseau et al.   HISTOPATHOLOGY

High Frequency of Endothelial Colony Forming Cells Marks a Non-Active Myeloproliferative Neoplasm with High Risk of Splanchnic Vein Thrombosis

(2010) Vittorio Rosti et al.   PLoS One

JAK2V617F-Positive Latent Essential Thrombocythemia and Splanchnic Vein Thrombosis: The Role of Bone Marrow Biopsy for the Diagnosis of Myeloproliferative Disease

(2009) Alessandro Allegra et al.   ACTA HAEMATOLOGICA

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

(2009) F. Passamonti et al.   BLOOD

JAK2V617F allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis

(2009) Kais Hussein et al.   EXPERIMENTAL HEMATOLOGY

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

(2008) F. Cervantes et al.   BLOOD